| Ms Anna D Delaney, MS CCC-SLP | |
|
52nd Medical Group, Unit 3690, Apo, AE 09126-3690 | |
| (496) 565-618511 | |
| Not Available |
| Full Name | Ms Anna D Delaney |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 52nd Medical Group, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174832760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3637 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Anna D Delaney, MS CCC-SLP 52nd Medical Group, Unit 3690, Apo, AE 09126-3690 Ph: () - | Ms Anna D Delaney, MS CCC-SLP 52nd Medical Group, Unit 3690, Apo, AE 09126-3690 Ph: (496) 565-618511 |
News Archive
Today is the official launch of a newly formed Coalition of medical, mental health, higher education, student and pharmaceutical organizations that will work together to help prevent misuse, abuse and diversion of ADHD prescription stimulant medication. The Coalition will initially focus its efforts on college students.
Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).
The ongoing COVID-19 pandemic is caused by the severe acute respiratory syndrome-2 (SARS-CoV-2), an RNA virus that belongs to the family Coronaviridae. According to research, coronavirus disease 2019 (COVID-19) patients often suffer from neurological disorders like strokes, lost taste or smell, memory loss, confusion, and delirium.
The U.S. Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed the drug prolonged survival by 20 months.
Officials will launch a marketing campaign in conjunction with the NCAA college basketball tournaments - events they view as offering great potential for reaching young people and urging them to get health insurance.
› Verified 9 days ago
Mr. Gregory Michael Jablonski, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Cmr 427 Box 2385, Apo, AE 09630 Phone: 390-444-717471 Fax: 390-444-717222 | |
Mrs. Carlie Gingrich, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 637-194-646127 | |
Tracie Treharne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Cmr 402 Box 281, Apo, AE 09180 Phone: 496-371-94645298 | |
Jeanne Schorsch, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7028 | |
Andrea L Loudermilk-shull, MS., CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 52 Mdos/sgov, Unit 3690, Apo, AE 09126 Phone: 004-965-6169 | |
Michael Pezzullo, SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Usa Meddac Bavaria, Cmr 411, Bldg 700, Rose Barracks, Apo, AE 09112 Phone: 499-662-834719 Fax: 499-662-834721 |